Brinker Capital Investments, LLC Fibrogen Inc Transaction History

Brinker Capital Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$18.57 - $35.68 $407,240 - $782,462	-21,930 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$31.0 - $55.72 $665,849 - $1.2 Million	-21,479 Reduced 49.48%	21,930 $761,000
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $385,513 - $508,994	10,394 Added 31.48%	43,409 $1.61 Million
Q3 2020 Dec 03, 2020	BUY	$40.47 - $45.5 $1.34 Million - $1.5 Million	33,015 New	33,015 $1.36 Million
Q1 2020 May 13, 2020	SELL	$23.3 - $45.96 $2,050 - $4,044	-88 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$34.58 - $48.06 $3,043 - $4,229	88 New	88 $4,000

115

57.5M

2.14M

907K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $37.5M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.